NuGen Medical Devices Inc (NGMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has a cash flow conversion efficiency ratio of 0.066x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.01 Million ≈ $-729.17K USD) by net assets (CA$-15.33 Million ≈ $-11.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NGMD market cap overview for the company's overall valuation and market capitalisation.
NuGen Medical Devices Inc - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NuGen Medical Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NuGen Medical Devices Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of NuGen Medical Devices Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
0.032x |
|
CL8 Holdings Ltd
AU:CL8
|
0.158x |
|
Clean & Carbon Energy S.A.
WAR:CCE
|
-0.044x |
|
John Wood Group PLC
LSE:WG
|
-0.763x |
|
SIGNATURE RESOURCES NEW
F:3S30
|
1.468x |
|
Lanesborough Real Estate Investment Trust
V:LRT-UN
|
0.011x |
|
ROUTE1 INC.
F:3R6N
|
-0.683x |
|
ILYA Co. Ltd
KQ:058450
|
-0.054x |
Annual Cash Flow Conversion Efficiency for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual cash flow conversion efficiency of NuGen Medical Devices Inc from 2020 to 2025. View NGMD share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-13.74 Million ≈ $-9.94 Million |
CA$-3.57 Million ≈ $-2.58 Million |
0.260x | -68.76% |
| 2024-12-31 | CA$-5.67 Million ≈ $-4.10 Million |
CA$-4.71 Million ≈ $-3.41 Million |
0.831x | -74.50% |
| 2023-12-31 | CA$-2.06 Million ≈ $-1.49 Million |
CA$-6.71 Million ≈ $-4.86 Million |
3.259x | +51.03% |
| 2022-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-4.88 Million ≈ $-3.53 Million |
2.158x | +187.35% |
| 2021-12-31 | CA$1.66 Million ≈ $1.20 Million |
CA$-4.10 Million ≈ $-2.96 Million |
-2.470x | -222.69% |
| 2020-12-31 | CA$-692.25K ≈ $-500.76K |
CA$-1.39 Million ≈ $-1.01 Million |
2.013x | -- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more